Almac to feature Expert Speakers at Upcoming DIA Annual Meeting

June 11, 2010

Almac announces that six of its experts will be presenting at the upcoming Drug Information Association (DIA) Conference in Washington, D.C. The 46th annual DIA conference, the largest industry trade show, will draw over 8,000 attendees and will be held at the WalterE.WashingtonConvention Center in Washington, D.C. from June 13 – 17, 2010.

Jim Murphy, President of Almac’s Clinical Technologies division states: “As a leader in our industry, Almac possesses some of the foremost experts in Integrated Technology and Drug Supply Management Solutions. Six of our thought leaders will be appearing at podiums with some of the world’s leading experts from biopharmaceutical firms. I am excited that Almac will be a contributing to one of the most educational conferences of the year.”

Six Almac professionals were selected to speak on the following topics:

• Leslie Darling, Client Development Lead; “Understanding the Benefits and Limitations of Drug Pooling”; Session # 125; June 14, 1:30PM

• Julie Jacobs, Director, Project Services; “Understanding the Benefits and Limitations of Drug Pooling”; Session # 125; June 14, 1:30PM

• Carl Labb, Manager, New Products and Services, “Standards-based Approach to Creating One Elegant Multisystem Solution”; Session #154; June 14, 3:30PM

• Joseph Bedford, PhD, Director, Marketing; “Managing Strategic Partnering Relationships in R&D”; Session #435; June 17, 10:30AM

• Theresa Hummel-Krallinger, Director, Organizational Development and Training; “Cultural Awareness in a Global Workplace”; Session # 436; June 17, 10:30AM

• Jennifer Ross, Biostatistician; “Planning the Design of an Adaptive Randomization Algorithm with the use of Monte Carlo Simulation Methods”; Poster Session T39; June 15, 12:00PM

In addition to featuring its speakers at the DIA conference, Almac also announced earlier this week that it will be launching a revolutionary advance in its integrated phone and web technology, known as IXRS®. The new version, IXRS® 2.0 offers users powerful new web-based tools, such as smart menus and intuitive navigation, to speed tasks, improve workflow and drive efficiencies in managing patients and drug supplies during clinical trials. A live demo of IXRS® 2.0 will be featured at the Almac booth along with the firm’s recent release of its powerful new reporting suite, Almac Interactive Reporting.

About Almac Clinical Technologies

Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS®) for patient randomization, tracking and clinical supply management; electronic patient reported outcomes data collection; and Web drug reconciliation. Almac’s technologies have been deployed in over 1450 clinical trials, incorporating over 1.5 million patients in over 80 countries and more than 60 languages.

About Almac Group:

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS & Web), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,600 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $120m North American Headquarters started in July 08 and will be completed 2010. Almac was awarded Northern Ireland’s “Business of the Year” award in 2009.

For more information about the Almac Group, please visit or e-mail [email protected].


Back to news